Abstract
Purpose
To review the literature regarding any clinically significant association between prostate size and the incidence of prostate cancer (PCa). No previous review or meta-analysis has reported this clinical question.
Methods
A thorough literature review was performed using PubMed and applying the ‘PRISMA’ guidelines. Inclusion and exclusion criteria were defined.
Results
A total of 30 articles met the search criteria. Of these 30 articles, 27 reported an inverse correlation between prostate volume (PV) and incidence of biopsy-proven PCa. The remaining three articles provided no clear statistically significant results, and there was no study showing a direct or positive correlation between PV and the incidence of PCa.
Conclusion
This review and meta-analysis is the first report summarizing the literature on the clinical question of whether prostate size affects the incidence of PCa. Ninety percent of studies (27/30) show significant evidence supporting the hypothesis that prostate size may be protective of PCa. This review and the outlined discussion should encourage other clinical investigators to explore the relationship between PV and the incidence and aggressiveness of PCa. If future studies should confirm the hypothesis of the dynamic interactions between the different prostatic zones in a growing prostate, it will have relevant clinical implications on the management of BPH and PCa.
Similar content being viewed by others
Availability of data and materials
All data sets were extracted from PubMed.
Code availability
REVMAN software was used to quantify the various data sets.
Abbreviations
- PCa:
-
Prostate cancer
- BPH:
-
Benign prostatic hyperplasia
- PV:
-
Prostate volume
- TRUS:
-
Transrectal ultrasound
- CG:
-
Central gland
- TZ:
-
Transitional zone
- PZ:
-
Peripheral zone
References
Ørsted DD, Bojesen SE (2013) The link between benign prostatic hyperplasia and prostate cancer. Nat Rev Urol 10(1):49–54
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
PRISMA (2021) http://www.prisma-statement.org/ Accessed 21 Feb 2021.
Al-Azab R, Toi A, Lockwood G, Kulkarni GS, Fleshner N (2007) Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostatespecific antigen values between 2.0 and 9.0 ng/mL. Urology. 69(1):103–107
Al-Khalil S, Ibilibor C, Cammack JT, de Riese W (2016) Association of prostate volume with incidence and aggressiveness of prostate cancer. Res Rep Urol 26(8):201–205
Karakiewicz PI, Bazinet M, Aprikian AG, Trudel C, Aronson S, Nachabé M, Péloquint F, Dessureault J, Goyal MS, Bégin LR, Elhilali MM (1997) Outcome of sextant biopsy according to gland volume. Urology 49(1):55–59
Briganti A, Chun FK, Suardi N, Gallina A, Walz J, Graefen M, Shariat S, Ebersdobler A, Rigatti P, Perrotte P, Saad F, Montorsi F, Huland H, Karakiewicz PI (2007) Prostate volume and adverse prostate cancer features: fact not artifact. Eur J Cancer 43(18):2669–2677
Hong SK, Poon BY, Sjoberg DD, Scardino PT, Eastham JA (2014) Prostate size and adverse pathologic features in men undergoing radical prostatectomy. Urology 84(1):153–157
de Gorski A, Rouprêt M, Peyronnet B, Le Cossec C, Granger B, Comperat E, Cussenot O, Renard-Penna R, Mozer P (2015) Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates. J Urol 194(3):669–673
Peng Y, Shen D, Liao S, Turkbey B, Rais-Bahrami S, Wood B, Karademir I, Antic T, Yousef A, Jiang Y, Pinto PA, Choyke PL, Oto A (2015) MRI-based prostate volume-adjusted prostate- specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging 42(6):1733–1739
Yilmaz H, Ustuner M, Ciftci S, Yavuz U, Ozkan TA, Dillioglugil O (2014) Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients. Int Braz J Urol 40(5):613–619
Lorenzo G, Hughes TJR, Dominguez-Frojan P, Reali A, Gomez H (2019) Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth. Proc Natl Acad Sci US A 116(4):1152–1161
Guzman JA, Sharma P, Smith LA, Buie JD, de Riese WT (2019) Histological changes of the peripheral zone in small and large prostates and possible clinical implications. Res Rep Urol 21(11):77–81
Matsugasumi T, Fujihara A, Ushijima S, Kanazawa M, Yamada Y, Shiraishi T, Hongo F, Kamoi K, Okihara K, de Castro Abreu AL, Oishi M, Shin T, Palmer S, Gill IS, Ukimura O (2007) Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan. BJU Int. https://doi.org/10.1111/bju.13823
Funding
No specific grant was associated with this study.
Author information
Authors and Affiliations
Contributions
WT.dR, JC, and AM contributed to the study conception and design. Material preparation, literature review, data collection, and analysis were mainly performed by AM. The first draft of the manuscript was written by AM and reviewed by WT.dR and JC. WT.dR and JC commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moolupuri, A., Camacho, J. & de Riese , W.T. Association between prostate size and the incidence of prostate cancer: a meta-analysis and review for urologists and clinicians. Int Urol Nephrol 53, 1955–1961 (2021). https://doi.org/10.1007/s11255-021-02892-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02892-w